Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus
A 72-year-old man presented with a super-refractory partial status epilepticus following evacuation of a right subdural hematoma. He failed to respond to treatment with high doses of intravenous valproic acid, Levetiracetam, Lacosamide, Thiopental, and Midazolam. He was given 4 mg of Perampanel oral...
Saved in:
Main Authors: | Abdallah Rahbani, Grace Adwane, Najo Jomaa |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2019-01-01
|
Series: | Case Reports in Neurological Medicine |
Online Access: | http://dx.doi.org/10.1155/2019/8537815 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Super-Refractory Status Epilepticus Treated with High Dose Perampanel: Case Series and Review of the Literature
by: Christopher R. Newey, et al.
Published: (2019-01-01) -
Updates in Refractory Status Epilepticus
by: Rohit Marawar, et al.
Published: (2018-01-01) -
Evolution of Cerebral Atrophy in a Patient with Super Refractory Status Epilepticus Treated with Barbiturate Coma
by: Christopher R. Newey, et al.
Published: (2017-01-01) -
Early initiation of intravenous cyclophosphamide and one‐year outcome in super‐refractory cryptogenic‐new onset refractory status epilepticus
by: Yasufumi Yorichika, et al.
Published: (2025-02-01) -
Propylene Glycol Toxicity in Adolescent with Refractory Myoclonic Status Epilepticus
by: Kara A. Bjur, et al.
Published: (2017-01-01)